Maturitas
Volume 60, Issue 3 , Pages 239-243 , July 2008

The validity of the Menopause Specific Quality of Life Questionnaire in older women

  • Sujeetha Kulasingam

      Affiliations

    • Geriatric Research Unit, Neurosciences, Sunnybrook Health Sciences Centre, Canada
    • ,
  • Rahim Moineddin

      Affiliations

    • Department of Family and Community Medicine and Department of Public Health Sciences, University of Toronto, and Institute for Clinical Evaluative Sciences, Canada
    • ,
  • Jacqueline E. Lewis

      Affiliations

    • Department of Family Medicine, University of Calgary, Canada
    • ,
  • Mary C. Tierney

      Affiliations

    • Geriatric Research Unit, Neurosciences, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5 and Department of Family and Community Medicine, University of Toronto
    • Corresponding Author InformationCorresponding author. Tel.: +1 416 480 4291; fax: +1 416 480 6776.

Received 8 February 2008 ,Revised 10 June 2008 ,Accepted 18 July 2008.

References 

  1. Hilditch J, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996;24:161–175
  2. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the menopause-specific quality of life questionnaire and development of a modified version, MENQOL-intervention questionnaire. Maturitas. 2005;50(March (3)):209–221
  3. Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms. Gynecol Obstet Invest. 2005;59(4):212–219
  4. Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Med J Aust. 2001;174(January (2)):68–71
  5. Serrano D, Mariani L, Mora S, et al. Quality of life assessment in a chemoprevention trial: Fenretinide and oral or transdermal HRT. Maturitas. 2006;(February):
  6. Whelan TJ, Goss PE, Ingle JN, et al. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol. 2005;23(October (28)):6931–6940
  7. Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas. 2007;56(January (1)):45–53
  8. Limpaphayom KK, Darmasetiawan MS, Hussain RI, Burriss SW, Holinka CF, Ausmanas MK. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Climacteric. 2006;9(June (3)):204–214
  9. Peeyananjarassri K, Cheewadhanaraks S, Hubbard M, Zoa MR, Manocha R, Eden J. Menopausal symptoms in a hospital-based sample of women in southern Thailand. Climacteric. 2006;9(February (1)):23–29
  10. Friedman SH, Sajatovic M, Schuermeyer IN, et al. Menopause-related quality of life in chronically mentally ill women. Int J Psychiatry Med. 2005;35(3):259–271
  11. St-Arnaud J, Beaudet MP, Tully P. Life expectancy. Health Rep. 2005;17(November (1)):43–47
  12. Report: Health expectancies in the UK, 2002. Health Stat Q 2006;(29):59–62.
  13. Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1996; 866:1–107.
  14. Zollner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res. 2005;14(March (2)):309–327
  15. Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res. 2005;14(September (7)):1651–1668
  16. Andresen EM, Bowley N, Rothenberg BM, Panzer R, Katz P. Test-retest performance of a mailed version of the medical outcomes Study 36-Item short-form health survey among older adults. Med Care. 1996;34(December (12)):1165–1170
  17. Chia EM, Chia EM, Rochtchina E, Wang JJ, Mitchell P. Utility and validity of the self-administered SF-36: findings from an older population. Ann Acad Med Singapore. 2006;35(July (7)):461–467
  18. Kempen GI, Brilman EI, Ranchor AV, Ormel J. Morbidity and quality of life and the moderating effects of level of education in the elderly. Soc Sci Med. 1999;49(July (1)):143–149
  19. Kotz K, Alexander JL, Dennerstein L. Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women. J Womens Health. 2006;15(October (8)):898–908
  20. Gott M, Hinchliff S. How important is sex in later life? The views of older people. Soc Sci Med. 2003;56(April (8)):1617–1628
  21. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49
  22. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149(December):698–709
  23. Tierney MC, Szalai JP, Snow WG, Fisher RH. The prediction of Alzheimer's disease: the role of patient and informant perceptions of cognitive deficits. Arch Neurol. 1996;53:423–427
  24. Neugarten BL, Kraines RJ. “Menopausal symptoms” in women of various ages. Psychosom Med. 1965;27(May):266–273
  25. Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol. 2002;100(December (6)):1209–1218

PII: S0378-5122(08)00200-4

doi: 10.1016/j.maturitas.2008.07.002

Maturitas
Volume 60, Issue 3 , Pages 239-243 , July 2008

Article Tools